Home › Research › Brain scans and imaging
Blood Phosphorylated Tau for the Diagnosis of Alzheimer Disease
Alexis S. Dadelahi, Melissa M. Budelier. Clinical Chemistry, 2026-04-21
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Alzheimer disease (AD) is the leading cause of dementia globally and is defined by the presence of amyloid-β (Aβ) plaques and neurofibrillary tangles formed by the accumulation of phosphorylated tau (p-tau). This biological evidence, combined with clinical symptoms of cognitive impairment, is used to diagnose AD, typically in a secondary or tertiary care setting. AD pathology can be identified using positron emission tomography (PET; amyloid-PET and tau-PET) or through biofluid testing, including measurement of p-tau181/Aβ 42, total tau/Aβ 42, or Aβ 42/40 in cerebrospinal fluid (CSF) (1). Due to limited access to PET imaging and the reluctance of some patients to undergo lumbar puncture, the recent emergence of blood-based biomarkers (BBMs) has garnered significant interest as a lower-cost and highly accessible alternative for identifying biological evidence of disease. However, variability in assay performance and uncertainty in interpreting results in the general population raise concerns about widespread clinical implementation of BBM assays.
What this study adds
Evidence grade: Low
This article discusses blood-based biomarkers as a lower-cost, more accessible alternative to PET imaging and lumbar puncture for identifying biological evidence of Alzheimer's disease. It notes that variability in assay performance and uncertainty in interpreting results in the general population raise concerns about widespread clinical use.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Dadelahi, A. S., & Budelier, M. M. (2026). Blood Phosphorylated Tau for the Diagnosis of Alzheimer Disease. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvag048
Vancouver
Dadelahi AS, Budelier MM. Blood Phosphorylated Tau for the Diagnosis of Alzheimer Disease. Clinical Chemistry. 2026. doi:10.1093/clinchem/hvag048. PMID: 42201264.
BibTeX
@article{dadelahi2026-42201264,
author = {Dadelahi, Alexis S. and Budelier, Melissa M.},
title = {{Blood Phosphorylated Tau for the Diagnosis of Alzheimer Disease}},
journal = {Clinical Chemistry},
year = {2026},
doi = {10.1093/clinchem/hvag048},
pmid = {42201264},
url = {https://doi.org/10.1093/clinchem/hvag048}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Due to limited access to PET imaging and the reluctance of some patients to undergo lumbar puncture, the recent emergence of blood-based biomarkers (BBMs) has garnered significant interest as a lower-cost and highly accessible alternative for identifying biological evidence of disease.
- However, variability in assay performance and uncertainty in interpreting results in the general population raise concerns about widespread clinical implementation of BBM assays.
Why it matters
This article discusses blood-based biomarkers as a lower-cost, more accessible alternative to PET imaging and lumbar puncture for identifying biological evidence of Alzheimer's disease. It notes that variability in assay performance and uncertainty in interpreting results in the general population raise concerns about widespread clinical use.
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Evidence strengthLow
How this study scored 30/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Clinical Chemistry) |
| Journal's citation record | 3 / 4 | Clinical Chemistry: journal h-index 323 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Melissa M. Budelier: h-index 15 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of New Mexico: institution h-index 845 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 42201264) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 30 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Brain scans and imaging from nearby years
Also tagged “phosphorylated”
732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.